CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioray Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioray Biotech Co Ltd
No.1, Dali 2nd Road, Shanhua District
Phone: +886 87626868p:+886 87626868 TAINAN, 741  Taiwan Ticker: 75617561
Business Summary
Bioray Biotech Co Ltd is a Taiwan-based company mainly engaged in the production of health products, as well as the Own Designing & Manufacturing and Original Equipment Manufacturing (ODM/OEM) business. The Company also provides functional medical testing services, as well as cell storage and preparations business. The health products include personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract, anti-arthritis probiotics, among others. The testing services include personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic related genes, lymphocyte grouping. The cell storage and preparations include stem cell storage, immune cell storage, cytokine induced killer (CIK) immune cell preparations, among others.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5499 Miscellaneous food stores
2099 Food preparations, not elsewhere classified
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ChunmeiLu 1/1/2024 6/28/2019
General Manager Ting-YuanHsu 1/1/2024 1/1/2024
Head of Finance & Accounting Cheng ShunKuo 10/6/2020 10/6/2020
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 30,085,000 (As of 6/30/2023)
Stock Exchange: TPO
Fax Number: +886 87623751


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024